BioAge Labs, Inc. (BIOA) income statement
BIOANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/30
$4.77−0.33 (-6.47%)
Close on Nov 18, 2026Market cap $218.93MP/E –Yield –
BioAge Labs, Inc. income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -1026.3%
- Net margin
- -912.3%
- Return on equity, FY2025
- -27.1%
Financial strength
- Current ratio
- 17.19
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 384.9%
Valuation
- P/E ratio
- –
- Price to sales
- 21.14
- Price to book
- 0.58
- Dividend yield
- –
See a number that looks wrong?